Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus

Christopher T.A. Lewis, Roger Moreno-Justicia, Lola Savoure, Enrique Calvo, Agata Bak, Jenni Laitila, Robert A.E. Seaborne, Steen Larsen, Hiroyuki Iwamoto, Marina Cefis, Jose A. Morais, Gilles Gouspillou, Jorge Alegre-Cebollada, Thomas J. Hawke, Jesús Vazquez, Miquel Adrover, Vincent Marcangeli, Rami Hammad, Jordan Granet, Pierrette GaudreauMylène Aubertin-Leheudre, Marc Bélanger, Richard Robitaille, Atul S. Deshmukh, Julien Ochala*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)

Abstract

Aims/hypothesis: Disrupted energy balance is critical for the onset and development of type 2 diabetes mellitus. Understanding of the exact underlying metabolic mechanisms remains incomplete, but skeletal muscle is thought to play an important pathogenic role. As the super-relaxed state of its most abundant protein, myosin, regulates cellular energetics, we aimed to investigate whether it is altered in individuals with type 2 diabetes. Methods: We used vastus lateralis biopsy specimens (obtained from patients with type 2 diabetes and control participants with similar characteristics), and ran a combination of structural and functional assays consisting of loaded 2′- (or 3′)-O-(N-methylanthraniloyl)-ATP (Mant-ATP) chase experiments, x-ray diffraction and LC-MS/MS proteomics in isolated muscle fibres. Results: Our studies revealed a greater muscle myosin super-relaxation and decreased ATP demand in male participants with type 2 diabetes than in control participants. Subsequent proteomic analyses indicated that these (mal)adaptations probably originated from remodelled sarcomeric proteins and greater myosin glycation levels in patients than in control participants. Conclusions/interpretation: Overall, our findings indicate a complex molecular dysregulation of myosin super-relaxed state and energy consumption in male participants with type 2 diabetes. Ultimately, pharmacological targeting of myosin could benefit skeletal muscle and whole-body metabolic health through enhancement of ATP consumption. Data availability: The raw MS data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD053022.

Original languageEnglish
Pages (from-to)1836-1850
Number of pages15
JournalDiabetologia
Volume68
Issue number8
Early online date28 Apr 2025
DOIs
Publication statusE-pub ahead of print - 28 Apr 2025

Keywords

  • Diabetes
  • Metabolism
  • Myosin
  • Skeletal muscle

Fingerprint

Dive into the research topics of 'Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this